Abdallah Flaifel

7PUBLICATIONS
27CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 18, 2021
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial.

Thomas Denize, Subrina Farah, Alessia Cimadamore

|Nov 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma.

Miriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo

|Sep 03, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.

Nizar M Tannir, Sabina Signoretti, Toni K Choueiri

|Apr 24, 2020
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors.

Sarah Abou Alaiwi, Amin H Nassar, Wanling Xie

|Aug 03, 2019
PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN.

Abdallah Flaifel, Wanling Xie, David A Braun

|Oct 31, 2018
Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival.

Matthew G Oser, Raquel Fonseca, Abhishek A Chakraborty

Pageof 2